(Q45742451)

English

Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33).

scientific article published in June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33). (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

0 references

author name string

Goldstein G

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Manson K

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Tribbick G

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Smith R

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

18

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

25

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

2789-2795

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High levels of circulating RNA in patients with symptomatic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 Tat protein as a potential AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat protein induces self-perpetuating permissivity for productive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple peptide synthesis on acid-labile handle derivatized polyethylene supports.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for preparing beta-hCG COOH peptide-carrier conjugates of predictable composition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional and Immunological Characterization of SIV Envelope Glycoprotein Produced in Genetically Engineered Mammalian Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-antibody interactions at the molecular level: adventures in peptide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic antibodies elicited by immunization against TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat-independent replication of human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900085-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00085-2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10812220

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45742451&oldid=1775311251"